US Edition
News from thailandtribune.com
If you want to know if thailandtribune.com is credible or reliable, look no further. We rank thailandtribune.com as Unknown factuality. Find out more about our methodology here.
Information about thailandtribune.com
Where is thailandtribune.com located?thailandtribune.com's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top thailandtribune.com News
Business · TaiwanTAIPEI, Taiwan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Moonup Technology Co., Ltd., the Taiwan operations partner of European smart home leader Shelly (Shelly Group), announced its major participation in the 2025 Taipei Building Show to be held from December 11 to December 14 at Nangang Exhibition Center. The company will present Shelly's complete smart building and smart home ecosystem under the central theme "Minimal Renovation, Maximum Intelligenc…See the Story
Moonup Technology Partners with European Smart Home Leader Shelly to Showcase Full Smart Building Ecosystem at the 2025 Taipei Building Show
67% Left coverage: 9 sources
European Union · Bergisch GladbachDALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time of 14-16 d…See the Story
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting
43% Left coverage: 7 sources
Richardson · RichardsonMavenir announces a strong leadership team to accelerate its vision for telco-first, cloud-native, AI-by-design networks, and a refreshed product strategy...See the Story
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy
34% Center coverage: 3 sources
